✦ LIBER ✦
Phase III study of PSC-833 (valspodar) in combination with vincristine, doxorubicin, and dexamethasone (valspodar/VAD) versus VAD alone in patients with recurring or refractory multiple myeloma (E1A95) : A trial of the Eastern Cooperative Oncology Group
✍ Scribed by William R. Friedenberg; Montserrat Rue; Emily A. Blood; William S. Dalton; Chaim Shustik; Richard A. Larson; Pieter Sonneveld; Philip R. Greipp
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 149 KB
- Volume
- 106
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.